Ocugen Inc (OCGN)

Dec 24, 2025

Ocugen Shares Navigate Year-End Consolidation Phase - AD HOC NEWS

Dec 24, 2025

Dec 23, 2025

Ocugen’s Pipeline Progress: Targeting Unmet Needs in Rare Eye Diseases - AD HOC NEWS

Dec 23, 2025

Dec 23, 2025

Is Ocugen’s (OCGN) Rare Disease Summit Spotlight Reframing Its Gene Therapy Investment Narrative? - Yahoo Finance

Dec 23, 2025

Dec 23, 2025

Is Ocugen (OCGN) Quietly Reframing Its Risk Profile Around Rare Disease Gene Therapies? - simplywall.st

Dec 23, 2025

Dec 21, 2025

Why Ocugen Inc. stock is a must watch in 2025Energy Sector Updates & Achieve Triple Digit Returns - Bollywood Helpline

Dec 21, 2025

Dec 20, 2025

Why Ocugen Inc. (2H51) stock stays on top picksOptions Play & Community Verified Trade Signals - Улправда

Dec 20, 2025

Dec 19, 2025

Can Ocugen Inc. stock weather global recession2025 Analyst Calls & Free Weekly Chart Analysis and Trade Guides - ulpravda.ru

Dec 19, 2025

Dec 19, 2025

Bear Alert: Can Ocugen Inc. stock weather global recessionJuly 2025 Weekly Recap & Risk Managed Investment Strategies - Улправда

Dec 19, 2025

Dec 19, 2025

Will Ocugen Inc. stock deliver strong dividend growth2025 Macro Impact & Verified Trade Idea Suggestions - Улправда

Dec 19, 2025

Dec 19, 2025

Ocugen Ties CEO Compensation to Regulatory and Stock Performance - AD HOC NEWS

Dec 19, 2025

Dec 19, 2025

Is Ocugen Inc. (2H51) stock dividend growth reliable2025 Trading Volume Trends & Technical Entry and Exit Tips - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Why Ocugen Inc. (2H51) stock is listed among top recommendationsMarket Performance Summary & Weekly Consistent Profit Watchlists - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Will Ocugen Inc. stock maintain growth story2025 Risk Factors & Low Drawdown Trading Strategies - DonanımHaber

Dec 19, 2025

Dec 18, 2025

Ocugen Grants CEO New Performance-Based Equity Award - TipRanks

Dec 18, 2025

Dec 18, 2025

Pharma News: Why Ocugen Inc. stock is a must watch in 2025July 2025 Summary & Risk Adjusted Buy and Sell Alerts - Улправда

Dec 18, 2025

Dec 18, 2025

Why pension funds invest in Ocugen Inc. (2H51) stockAnalyst Upgrade & Safe Entry Trade Reports - Улправда

Dec 18, 2025

Dec 17, 2025

Ocugen Shares Face Mounting Pressure Amid Financial Concerns - AD HOC NEWS

Dec 17, 2025

Dec 17, 2025

Ocugen Inc. Stock Rises Tuesday, Outperforms Market - 富途牛牛

Dec 17, 2025

Dec 16, 2025

Ocugen Inc. Stock Rises Monday, Outperforms Market - 富途牛牛

Dec 16, 2025

Dec 16, 2025

5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026 - Nasdaq

Dec 16, 2025

Dec 16, 2025

Ocugen (NASDAQ:OCGN) Shares Up 1.5%What's Next? - MarketBeat

Dec 16, 2025

Dec 15, 2025

How The Latest Analyst Shifts Are Reshaping Ocugen’s Story and Valuation - Yahoo Finance

Dec 15, 2025

Dec 13, 2025

Ocugen Inc Stock Analysis and ForecastSector Rotation Strategies & Free Rapid Growing Investment Returns - earlytimes.in

Dec 13, 2025

Dec 13, 2025

Growth Recap: Is Ocugen Inc stock supported by strong cash flowsJuly 2025 Review & Stepwise Trade Execution Plans - moha.gov.vn

Dec 13, 2025

Dec 12, 2025

Institutional Giant Janus Henderson Makes Major Bet on Ocugen - AD HOC NEWS

Dec 12, 2025

Dec 12, 2025

JANUS HENDERSON GROUP PLC Acquires Significant Stake in Ocugen I - GuruFocus

Dec 12, 2025

Dec 12, 2025

Ocugen Inc. stock rises Friday, outperforms market - MarketWatch

Dec 12, 2025

Dec 11, 2025

Ocugen Inc. stock rises Thursday, outperforms market - MarketWatch

Dec 11, 2025

Dec 11, 2025

Ocugen CEO’s Keynote Address Meets Heightened Market Skepticism - Ad-hoc-news.de

Dec 11, 2025

Dec 10, 2025

Ocugen Inc. stock rises Wednesday, outperforms market - MarketWatch

Dec 10, 2025

Dec 10, 2025

Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit - Ocugen

Dec 10, 2025

Dec 10, 2025

Ocugen, Inc. Chairman and CEO Dr. Shankar Musunuri to Present at Oppenheimer Movers in Rare Disease Summit - Quiver Quantitative

Dec 10, 2025

Dec 09, 2025

Major Fund Manager Acquires Significant Stake in Ocugen Amid Share Price Weakness - AD HOC NEWS

Dec 09, 2025

Dec 08, 2025

Ocugen Inc. stock falls Monday, underperforms market - MarketWatch

Dec 08, 2025

Dec 08, 2025

Ocugen Inc. Stock Falls Friday, Underperforms Market - 富途牛牛

Dec 08, 2025

Dec 08, 2025

Institutional Backing and Geopolitical Tailwinds for Ocugen - AD HOC NEWS

Dec 08, 2025

Dec 08, 2025

Ocugen Secures Validating Partnership for Gene Therapy Platform - AD HOC NEWS

Dec 08, 2025

Dec 05, 2025

How robust is Ocugen Inc. (2H51) stock financial positionMarket Volume Summary & Long Hold Capital Preservation Tips - Newser

Dec 05, 2025

Dec 05, 2025

Why institutional investors increase stakes in Ocugen Inc. (2H51) stockJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - Newser

Dec 05, 2025

Dec 05, 2025

How Ocugen Inc. (2H51) stock compares with tech leadersEarnings Growth Summary & Weekly Hot Stock Watchlists - Newser

Dec 05, 2025

Dec 05, 2025

Ocugen Inc. stock falls Friday, underperforms market - MarketWatch

Dec 05, 2025

Dec 04, 2025

Is Ocugen Inc. (2H51) stock resilient in recession scenarios2025 Stock Rankings & Weekly Watchlist of Top Performers - Newser

Dec 04, 2025

Dec 04, 2025

Why Ocugen Inc. stock appeals to analystsWeekly Trade Analysis & Risk Controlled Swing Alerts - Newser

Dec 04, 2025

Dec 04, 2025

Ocugen CEO to Spotlight Gene Therapy Breakthroughs at High-Profile Growth Conference - MSN

Dec 04, 2025

Dec 03, 2025

Can Ocugen Inc. (2H51) stock deliver consistent EPS growth2025 Volatility Report & Safe Capital Growth Stock Tips - Newser

Dec 03, 2025

Dec 02, 2025

Is Ocugen Inc. (2H51) stock good for long term investingRisk Management & Free Community Consensus Stock Picks - Newser

Dec 02, 2025

Dec 02, 2025

Ocugen Inc. stock falls Tuesday, underperforms market - MarketWatch

Dec 02, 2025

Nov 29, 2025

How the Narrative Surrounding Ocugen Is Shifting After New Licensing and Analyst Developments - Yahoo Finance

Nov 29, 2025

Nov 27, 2025

Ocugen to Announce Third-Quarter 2025 Results and Business Update on November 5 - MSN

Nov 27, 2025

Nov 27, 2025

Ocugen Receives FDA Greenlight for Phase 1 Trial of Mucosal COVID-19 Vaccine - MSN

Nov 27, 2025